Back to Currently Recruiting Trials

Chronic inducible urticaria

Chronic inducible urticaria trial

Study Details | A Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistamines | ClinicalTrials.gov

For more information, please contact:

Dr Nisal Punchihewa
t: 9623 9464
e: [email protected]

Register here

SIGN UP FOR OUR NEWSLETTER

Subscribe Now
Facebook Instagram Linkedin X-twitter

OPENING HOURS

Monday: 8am – 6pm
Tuesday: 8am – 6pm
Wednesday: 8am – 6pm
Thursday: 8am – 5pm
Friday: 8am – 5pm

CONTACT

Useful Links

© 2024 Skin Health Institute Inc.
Scroll to Top